Helping Clients With IBS: A Functional Medicine Guide

If you work with people — as a coach, trainer, therapist, or practitioner — roughly one in eight of your clients is dealing with IBS. Many of them haven’t told you. IBS carries enough stigma and frustration that people suffer silently, modifying their lives around symptoms rather than seeking help that they’ve learned to expect won’t work.

The functional medicine approach to IBS doesn’t start with “eat more fiber” or “reduce stress.” It starts with understanding which of the several distinct mechanisms is driving the symptoms in this specific person — because the intervention that helps one IBS patient can make another significantly worse.

We’ve covered the gut-brain axis extensively — and the vagus nerve pathway that carries signals between your gut and brain. This post applies that framework specifically to IBS and explains what the research says about root-cause approaches.

What’s actually happening

IBS isn’t a single disease. It’s a functional diagnosis — meaning it describes symptoms (abdominal pain, bloating, altered bowel habits) in the absence of structural disease. The Rome IV criteria define IBS by symptom pattern, not by mechanism.

This is the fundamental problem with treating IBS as one thing. Under the IBS umbrella are at least four distinct mechanisms:

SIBO (Small Intestinal Bacterial Overgrowth). Studies show that 60–80% of people diagnosed with IBS have SIBO — bacteria colonizing the small intestine where they shouldn’t be in significant numbers (Ghoshal et al., J Gastroenterol Hepatol, 2017 — https://pubmed.ncbi.nlm.nih.gov/27624800/). These bacteria ferment food in the wrong location, producing gas, bloating, and motility changes. A 2020 review in Beneficial Microbes detailed how SIBO disrupts the normal SCFA production patterns that maintain gut health (Blaak et al., 2020 — https://pubmed.ncbi.nlm.nih.gov/32865024/).

Post-infectious IBS. A significant percentage of IBS cases begin after a gastrointestinal infection. Klem et al. found that post-infectious IBS affects up to 10–15% of people after acute gastroenteritis (Gut, 2017 — https://pubmed.ncbi.nlm.nih.gov/27207866/). Anti-vinculin antibodies, produced in response to bacterial infection, can continue to damage the migrating motor complex (the “housekeeping wave” that clears the small intestine between meals) for months or years after the initial infection.

Visceral hypersensitivity. Some IBS patients have a nervous system that amplifies normal gut sensations. Gas volumes that wouldn’t register as discomfort in a healthy person produce significant pain. This is a gut-brain axis dysfunction — the vagus nerve and spinal afferents are amplifying signals rather than accurately reporting them.

Mast cell activation. Emerging research connects a subset of IBS to mast cell disorders. Increased mast cell density in the gut lining releases histamine and other mediators in response to food, stress, or microbial metabolites — producing pain, bloating, and motility changes that come and go unpredictably.

The neuroinflammation-immune pathway we covered is directly relevant — the same immune activation that drives brain fog drives IBS symptoms when localized to the gut.

Why this matters for functional practitioners

Standard IBS treatment — fiber supplements, antispasmodics, low-FODMAP diet — addresses symptoms without distinguishing mechanism. A low-FODMAP diet helps SIBO-driven IBS by reducing fermentable substrates, but it worsens the long-term microbiome health that prevents recurrence. Fiber supplements help motility-driven constipation-type IBS but can dramatically worsen bloating in SIBO patients.

This is the same distinction we drew in the fibermaxxing post — more fiber isn’t always better, and for IBS patients, it’s often worse. The mechanism has to come first.

For practitioners working with clients, the critical first step isn’t a dietary intervention — it’s a differential assessment that distinguishes between these mechanisms.

What you can do today

1. Ask about onset. Did the symptoms start after an infection, course of antibiotics, or period of high stress? Post-infectious IBS has a specific trajectory and treatment approach. Sudden onset suggests a trigger that’s identifiable.

2. Distinguish bloating from distension. Bloating (the sensation of fullness) and distension (visible abdominal swelling) can indicate different mechanisms. Visible distension after meals suggests SIBO or motility dysfunction. Bloating without visible swelling may indicate visceral hypersensitivity or mast cell activation.

3. Address meal timing. The migrating motor complex (MMC) — the “housekeeping wave” that sweeps the small intestine clean between meals — only activates during fasting. Eating every 2–3 hours prevents the MMC from completing its cycle. Space meals at least 4 hours apart and include a 12-hour overnight fast.

4. Consider SIBO testing. A lactulose or glucose breath test can detect SIBO. If positive, treatment with specific antimicrobials (either pharmaceutical or herbal) often produces dramatic improvement in IBS symptoms. Our coverage of the oral-gut-brain axis shows how bacterial overgrowth at any level of the GI tract affects brain function.

5. Support gut barrier integrity. L-glutamine (5–10g daily), bone broth, and colostrum support the tight junction proteins that keep the gut barrier intact. A compromised barrier amplifies visceral sensitivity and immune activation.

6. Vagus nerve support. Slow diaphragmatic breathing before meals activates the parasympathetic state needed for proper digestion. Our vagus nerve guide covers the specific protocols.

What to stop doing

Putting every IBS patient on a low-FODMAP diet. While it provides symptom relief in many cases, long-term FODMAP restriction reduces microbial diversity and can worsen the underlying dysbiosis. It’s a diagnostic tool (if symptoms improve, fermentation is a factor) and a short-term intervention — not a permanent dietary recommendation.

Ignoring the psychological component. The gut-brain axis means that IBS symptoms and psychological state are bidirectional. Cognitive behavioral therapy, gut-directed hypnotherapy, and vagal nerve stimulation all have clinical trial evidence for IBS improvement. This isn’t because IBS is “in your head” — it’s because the gut-brain axis runs both directions.

Assuming all IBS is the same. The mechanism matters. Treatment that helps one subtype can worsen another. Individualized assessment isn’t optional — it’s the difference between improvement and frustration.

The supplement question

Seed DS-01 Daily Synbiotic — Multi-strain synbiotic for microbiome restoration. Particularly useful for post-antibiotic or post-infectious IBS.

NOW Foods L-Glutamine Powder — Direct gut barrier support. 5–10g daily for intestinal permeability repair.

Phosphatidyl Serine 100mg (NOW Foods) — Supports the HPA axis modulation that reduces visceral hypersensitivity. Also helps with the sleep disruption that commonly accompanies IBS.

Life Extension Neuro-Mag Magnesium L-Threonate — Supports parasympathetic function and the vagal tone that drives proper motility.

What we still don’t know

The exact proportion of IBS subtypes in the general population is debated. SIBO prevalence estimates in IBS range from 30% to 80% depending on the diagnostic criteria and testing method used. Post-infectious IBS prevalence varies by geography and pathogen exposure. The heterogeneity of IBS means that single-mechanism treatments will always have variable results.

What’s improving: the recognition that IBS is not a wastebasket diagnosis but a set of identifiable, treatable mechanisms. The shift from “manage symptoms” to “identify and address the driving mechanism” is the most meaningful change in IBS care in decades.

Send this to someone who’s been told “it’s just IBS” and given a handout about fiber.